Quarter Financials

Intercept Pharmaceuticals Inc

Intercept Pharmaceuticals Inc (ICPT)

$39.09
-0.56 (-1.41%)

Income Statement

Balance Sheet Statement

Year 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4
Short-term debt -----------
Other Assets 19.9015.9014.7016.7116.3315.7116.0617.5519.8521.9121.67
Total current liabilities 104.0079.4088.7088.42114.20108.34125.23139.97162.00149.97163.54
Cash and cash equivalents 70.0048.9077.7059.3843.2554.7293.5063.3870.0641.4150.78
Long-term debt 355.70359.40363.30367.23371.25375.35545.01525.34532.08538.97546.01
Cash and short-term investments 414.90326.10538.30489.09436.16353.54758.52712.37652.62549.04534.48
Total debt 355.70359.40363.30367.23371.25375.35545.01525.34532.08538.97546.01
Inventories -----------
Deferred revenue 1.781.621.621.621.622.721.621.22---
Goodwill and Intangible Assets -----------
Total non-current liabilities 364.00366.70369.60372.73375.83384.92552.53531.38541.33547.13552.75
Total non-current assets 36.0030.0027.2028.0426.7435.4633.7833.0133.5734.1930.84
Total liabilities 468.00446.10458.30461.14490.04493.26677.77671.36703.33697.10716.29
Total assets 484.30393.80604.90556.95509.17438.26852.97802.09754.89662.38637.49
Other comprehensive income -0.80-0.60-2.10-1.65-2.26-1.17-0.84-1.07-1.14-3.80-1.13
Short-term investments 344.90277.20460.60429.71392.91298.82665.02648.99582.57507.63483.70
Property, Plant & Equipment Net 16.2014.1012.5011.3210.4119.7517.7215.4618.4517.2915.33
Net Debt 285.70310.50285.60307.85328.00320.63451.51461.96462.02497.56495.24
Investments 344.90277.20460.60429.71392.91298.82665.02648.99582.57507.63483.70
Total shareholders equity 16.40-52.30146.6095.8119.13-55.00175.20130.7451.56-34.72-78.80
Retained earnings (deficit) -1,469.50-1,551.10-1,626.30-1,690.78-1,778.79-1,869.06-1,940.47-2,025.31-2,123.47-2,216.45-2,279.73
Long-term investments -----------
Receivables -----------
Payables -----------
Total current assets 448.30363.80577.70528.92482.43402.80819.19769.08721.32628.19606.65

Cash Flow Statement

Year 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4
Operating Cash Flow -76.46-88.87-47.45-51.58-52.81-83.42-45.95-46.76-60.48-98.73-14.84
Free Cash Flow -76.75-88.96-47.41-51.58-52.93-84.16-46.24-46.77-60.58-99.16-15.07
Capital Expenditure -0.29-0.090.040.01-0.12-0.73-0.29-0.02-0.09-0.43-0.23
Depreciation & Amortization 1.341.291.141.121.032.402.21-1.770.820.760.81
Acquisitions and disposals -----------
Deferred income taxes -----------
Investment purchases -104.11-28.47-266.07-83.72-57.81-5.21-451.90-108.83-42.28-34.44-152.74
Accounts payables 12.71-20.695.523.4522.05-0.8015.4019.3922.42-7.9011.59
Sales/Maturities of investments ----388.17100.4181.16125.32108.26106.69-
Change in working capital 12.74-26.057.93-3.5418.82-14.943.1815.8615.23-28.1722.07
Debt repayment -----------
Other non-cash items 20.7317.4818.6815.2915.3419.3920.0823.9921.6221.6625.56
Investing Cash Flow 25.4066.72-183.2631.5436.9394.47-365.8216.4765.8971.8226.06
Cash at beginning of period 120.2070.0048.9077.7059.3843.2554.7293.5063.3870.0641.41
Stock-based compensation 15.3812.3014.1211.9911.5014.9014.7813.1313.1712.4716.08
Net cash flow / Change in cash -50.23-21.1428.85-18.34-16.1311.4838.78-30.1211.40-28.3610.52
Effect of forex changes on cash 0.070.53-1.800.44-0.690.28-0.05-0.730.12-0.69-1.15
Financing Cash Flow 0.760.48261.361.270.440.15450.600.895.88-0.750.44
Dividend payments -----------
Accounts receivables -2.01-0.44-2.56-2.57-3.61-3.75-6.923.54-5.22-6.554.34
Cash at end of period 69.9748.8677.7559.3643.2554.7293.5063.3874.7841.6951.93
Net cash provided by operating activities -76.46-88.87-47.45-51.58-52.81-83.42-45.95-46.76-60.48-98.73-14.84
Other working capital 344.27284.40489.04440.50368.22294.46693.96629.11559.31478.22443.12
Inventory 0.42-4.462.13-1.660.37-0.26-0.32-1.660.89-2.381.63

Retained Earning Schedule

Year 2017 Q4 2018 Q1 2018 Q2 2018 Q3 2018 Q4 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2
Net Income --82-75-64-88-90-71-85-98-93-63
Dividend Paid -----------
Retained Earnings -1,470-1,551-1,626-1,691-1,779-1,869-1,940-2,025-2,123-2,216-2,280

PPE Schedule

Year 2017 Q4 2018 Q1 2018 Q2 2018 Q3 2018 Q4 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2
Capital Expenditure -0-000-0-1-0-0-0-0-0
Net PPE 1614131110201815181715

Intangible and Goodwill Schedule

Year 2017 Q4 2018 Q1 2018 Q2 2018 Q3 2018 Q4 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2
New Purchases -104-28-266-84-58-5-452-109-42-34-153
Intangible and Goodwill -----------